Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Suspected Central Nervous System Tumors × Indocyanine Green × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 3 Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Suspected Central Nervous System Tumors 1 Stomach Neoplasms 1 Solitary Pulmonary Nodule 1 Multiple Pulmonary Nodules 1 Lymphedema 1 Head and Neck Neoplasms 1 Head and Neck Carcinoma 1 Giant Cell Tumor of Bone 1 Colorectal Neoplasms 1 Chylothorax 1 Breast Neoplasms 1

Interventions

Indocyanine Green 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02710240 2021-10-27

Indocyanine Green for Central Nervous System Tumors

Abramson Cancer Center at Penn Medicine

Phase 1/2 Completed

336 enrolled 7 charts

Suspected Central Nervous System Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡